The American Academy Of Pain Medicine

The physicians' voice in pain medicine
  • Foundation
  • Store
  • Career Center
  • Press
  • Join-Renew
Search: Go
Member Login: Login

Enter the AAPM
Members' Community

  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Safe Prescribing Resources
  • PI-CME Portal

Library

Home > Library > For Pain Researchers > 2013 Poster Abstracts
  • Research in the News
  • For Pain Researchers
    • 2013 Poster Abstracts
    • 2012 Poster Abstracts
    • Research Resources
    • Research Presentations
    • Search Clinical Trials (NIH)
    • Register a Clinical Trial (NIH)
    • Medline - US National Library of Medicine
  • Clinical Guidelines and Resources
  • Pain Facts
  • Archives
  • FDA Updates, Recalls and Warnings
  • Presented at the 2013 AAPM Annual Meeting « Back

    165

    Comparison Opioid Prescribing Guideline Violations by Clinical Specialty

    Chia-Chen Teng, MSTAT, chia-chen.teng@va.gov1, Christy Porucznik, PhD MSPH1, Erin Johnson, MPH2, Robert T. Rolfs, MD MPH2, Brian C. Sauer, PhD1, (1) University of Utah, Salt Lake City, Utah, (2) Utah Department of Health, Salt Lake City, Utah

    Objective: The objective of this analysis was to quantify the contribution of clinical speciality to the proportion of chronic opioid users who experienced unsafe prescribing according to the Utah Opioid Prescribing Guidelines that were promulgated in April of 2009. Methods: This study was IRB approved by the University of Utah. Multiple data sources were used for this analysis. Patient- and provider-level prescribing data were obtained from our prescription-monitoring program, the Utah Controlled Substances Database (CSD). ED visits were obtained using the Utah ED encounter database and information on opioid deaths was obtained from the state medical examiner database. Process flags included the dual use of long acting opioids and combined use of benzodiazepines and long acting opioids. Opioid uses were categorized as acute, intermittent, chronic or palliative. This analysis, however, was restricted to prescribing violations in chronic opioid users during the period of 04/2009 to 03/2010. Results: There were 36,364 patients who received opioids who were classified as chronic users during the study period. Long acting opioids were dispensed for 16,618 of these patients. Providers were involved in 953 long acting poly pharmacy flags and 8,198 long acting opioid and benzodiazepine flags. Nurse practitioners and pain medicine physicians had the highest proportion of chronic pain patients with long acting opioid flags. See figures 1 and 2. Conclusion: Nurse practitioners and pain physicians may need additional counseling on the Utah opioid prescribing guidelines and should review their panel of patients to ensure poly pharmacy is appropriate.

    Funding: CDC R21

    Poster 165a

    Poster 165b

  • Home
  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Contact Us
  • Members' Community
  • Privacy Policy
  • Sitemap
Close

Members Only Alert Message

Please login to access AAPM member only information.
Forgot your login information?

Sign Up Today!

Join AAPM today and be part of the primary organization for physicians practicing in the specialty of pain medicine and begin accessing AAPM member benefits. 

Join
Or

Log In

Please log in and you will be redirected to the requested page.

Log In